Sugi Predict

Sugi Predict / Compounds / SCHEMBL2445429

SCHEMBL2445429

SCHEMBL2445429

C=CN(C(=O)CCCCC)C(C)C

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.41
▸ CES2 O00748 4/20 0.40
▸ CES1 P23141 4/20 0.40
▸ FAAH O00519 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ LMNA P02545 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ AKR1B1 P15121 1/20 0.39
▸ FFAR4 Q5NUL3 1/20 0.38
▸ FFAR1 O14842 1/20 0.38
▸ SLC22A6 Q4U2R8 1/20 0.38
▸ SLC22A8 Q8TCC7 1/20 0.38
▸ GPR84 Q9NQS5 1/20 0.38
▸ PPARG P37231 1/20 0.38
▸ PPARD Q03181 1/20 0.38
▸ PPARA Q07869 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2443791 0.98 EPHX2 (0.46) EPHX2ALDH1A1CES2CES1FAAH
SCHEMBL2941814 0.98 EPHX2 (0.46) EPHX2ALDH1A1CES2CES1FAAH
SCHEMBL2442876 0.98 EPHX2 (0.46) EPHX2ALDH1A1CES2CES1FAAH
SCHEMBL2445477 0.98 EPHX2 (0.46) EPHX2ALDH1A1CES2CES1FAAH
SCHEMBL2945838 0.98 EPHX2 (0.46) EPHX2ALDH1A1CES2CES1FAAH
SCHEMBL2445048 0.98 EPHX2 (0.46) EPHX2ALDH1A1CES2CES1FAAH
SCHEMBL2441461 0.94 ALDH1A1 (0.47) EPHX2ALDH1A1CES2CES1FAAH
SCHEMBL2445338 0.86 ALDH1A1 (0.34) EPHX2ALDH1A1CES2CES1TSHR
SCHEMBL2443905 0.78 TSHR (0.37) ALDH1A1TSHR
SCHEMBL8092213 0.75 EPHX2 (0.41) EPHX2ALDH1A1CES2CES1FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10551345-B2 Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS, LLC (US) 2020-02-04 — — US claimed
US-20170356877-A1 POLY AND COPOLY(N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLIED BIOSYSTEMS, LLC (US) 2017-12-14 — — US claimed
US-9671367-B2 Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS, LLC (US) 2017-06-06 — — US claimed
US-20140209461-A1 Poly and Copoly(N-vinylamide)s and Their Use In Capillary Electrophoresis APPLIED BIOSYSTEMS, LLC (US) 2014-07-31 — — US claimed
EP-2053067-B1 Poly and copoly (N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS LLC (US) 2011-09-14 — — EP claimed
CN-101724216-A Poly and copolyn(N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS 2010-06-09 — — CN claimed
US-20100051461-A1 Poly and Copolyn(N-Vinylamide)s and their use in Capillary Electrophoresis Life Technologies Corporation (US) 2010-03-04 — — US claimed
CN-100567339-C (N-vinylamide) polymers and copolymers and their use in capillary electrophoresis APPLERA CORP (US) 2009-12-09 — — CN claimed
EP-2053067-A1 Poly and copoly (N-vinylamide)s and their use in capillary electrophoresis Applied Biosystems Inc. (US) 2009-04-29 — — EP claimed
EP-1636279-B1 POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLIED BIOSYSTEMS (US) 2009-02-18 — — EP claimed
CN-1816573-A (N-vinylamide) polymers and copolymers and their use in capillary electrophoresis APPLERA CORP (US) 2006-08-09 — — CN claimed
US-20050025741-A1 Copolymers with (meth)acrylamides; improved separation of polynucleotides APPLIED BIOSYSTEMS, LLC 2005-02-03 — — US claimed
CN-120025625-A Foaming composition and application thereof, foaming material and preparation method and application thereof 中国石油化工股份有限公司 2025-05-23 — — CN disclosed
CN-117986814-A Antibacterial biodegradable expanded beads, preparation method thereof, expanded bead molded body and application thereof 中国石油化工股份有限公司 2024-05-07 — — CN disclosed
CN-117946489-A Composite antibacterial agent, blown film, preparation method and application thereof, antibacterial biodegradable polyester composition, polyester material and preparation method 中国石油化工股份有限公司 2024-04-30 — — CN disclosed
US-20240118238-A1 COMPOSITIONS AND KITS COMPRISING INTERPENETRATING POLYMER NETWORK FOR CAPILLARY ELECTROPHORESIS HONGENE BIOTECH CORPORATION 2024-04-11 — — US disclosed
EP-2053067-A1 Poly and copoly (N-vinylamide)s and their use in capillary electrophoresis Applied Biosystems Inc. (US) 2009-04-29 — — EP disclosed
EP-1636279-B1 POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLIED BIOSYSTEMS (US) 2009-02-18 — — EP disclosed
CN-1816573-A (N-vinylamide) polymers and copolymers and their use in capillary electrophoresis APPLERA CORP (US) 2006-08-09 — — CN disclosed
US-20050025741-A1 Copolymers with (meth)acrylamides; improved separation of polynucleotides APPLIED BIOSYSTEMS, LLC 2005-02-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050025741-A1 Copolymers with (meth)acrylamides; improved separation of polynucleotides POLI, PCNA, POLL EPHX2 1822/4885ALDH1A1 3357/4885CES2 663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.